AMGEN INC Long Term Debt

• AMGEN INC showed a decrease of -11.6% in Long Term Debt from 2024 to 2025.
• This data is from AMGEN INC's annual report (Form 10-K), filed with the SEC on February 13, 2026.
• XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q2 2014: $30.83 billion | Q3 2014: $30.48 billion | Q1 2015: $29.84 billion | Q2 2015: $30.70 billion | Q3 2015: $30.51 billion | Q1 2016: $32.06 billion | Q2 2016: $27.93 billion | Q3 2016: $30.53 billion | Q1 2017: $30.29 billion | Q2 2017: $33.60 billion | Q3 2017: $33.78 billion | Q1 2018: $33.36 billion | Q2 2018: $30.21 billion | Q3 2018: $29.35 billion | Q1 2019: $29.32 billion | Q2 2019: $27.80 billion | Q3 2019: $27.74 billion | Q1 2020: $30.01 billion | Q2 2020: $34.13 billion | Q3 2020: $34.20 billion | Q1 2021: $31.13 billion | Q2 2021: $28.46 billion | Q3 2021: $33.29 billion | Q1 2022: $36.01 billion | Q2 2022: $35.71 billion | Q3 2022: $37.16 billion | Q1 2023: $60.76 billion | Q2 2023: $59.38 billion | Q3 2023: $59.04 billion | Q1 2024: $60.06 billion | Q2 2024: $57.12 billion | Q3 2024: $56.85 billion | Q1 2025: $54.01 billion | Q2 2025: $53.76 billion | Q3 2025: $52.43 billion.
• Over the full 13 years of available data (2013 to 2025), AMGEN INC's Long Term Debt has grown by 68.8%.
• Historical annual values: Fiscal year 2025: $50.01 billion | Fiscal year 2024: $56.55 billion | Fiscal year 2023: $63.17 billion | Fiscal year 2022: $37.35 billion | Fiscal year 2021: $33.22 billion | Fiscal year 2020: $32.90 billion | Fiscal year 2019: $26.95 billion | Fiscal year 2018: $29.51 billion | Fiscal year 2017: $34.19 billion | Fiscal year 2016: $30.19 billion | Fiscal year 2015: $29.18 billion | Fiscal year 2014: $30.22 billion | Fiscal year 2013: $29.62 billion.
• Data sourced from SEC EDGAR public filings as of August 4, 2026.

Last verified: August 4, 2026